Health
‘Not enough evidence’: Key taskforce rejects rollout of new COVID-19 drug – Sydney Morning Herald
A national taskforce says it cannot yet support the use of new treatment Sotrovimab, of which the federal government recently…
The governments purchase was supported by the federal governments science and industry technical advisory group, Mr Hunt said in a statement.
The taskforces recommendation was prior to the current assessment of Sotrovimab by the TGA, a spokesman for the…
Continue Reading